These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30938616)

  • 1. Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases (2013-2017).
    Elliott JW
    J Am Vet Med Assoc; 2019 Apr; 254(8):960-966. PubMed ID: 30938616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of toceranib for treatment of apocrine gland anal sac adenocarcinoma in dogs.
    Heaton CM; Fernandes AFA; Jark PC; Pan X
    J Vet Intern Med; 2020 Mar; 34(2):873-881. PubMed ID: 31977135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palmar-plantar erythrodysesthesia syndrome resulting from toceranib phosphate in a dog with apocrine gland anal sac adenocarcinoma: a case report.
    Kim E; Kim SS; Ryu MO
    J Vet Sci; 2023 Nov; 24(6):e76. PubMed ID: 37904638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary evidence for biologic activity of toceranib phosphate (Palladia(®)) in solid tumours.
    London C; Mathie T; Stingle N; Clifford C; Haney S; Klein MK; Beaver L; Vickery K; Vail DM; Hershey B; Ettinger S; Vaughan A; Alvarez F; Hillman L; Kiselow M; Thamm D; Higginbotham ML; Gauthier M; Krick E; Phillips B; Ladue T; Jones P; Bryan J; Gill V; Novasad A; Fulton L; Carreras J; McNeill C; Henry C; Gillings S
    Vet Comp Oncol; 2012 Sep; 10(3):194-205. PubMed ID: 22236194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of postoperative adjuvant treatment using toceranib phosphate against adenocarcinoma in dogs.
    Yamazaki H; Tanaka T; Mie K; Nishida H; Miura N; Akiyoshi H
    J Vet Intern Med; 2020 May; 34(3):1272-1281. PubMed ID: 32267594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toceranib phosphate (Palladia) for the treatment of canine exocrine pancreatic adenocarcinoma.
    Musser ML; Johannes CM
    BMC Vet Res; 2021 Aug; 17(1):269. PubMed ID: 34380474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological diagnosis and surgical complications following bilateral anal sacculectomy for the treatment of unilateral canine apocrine gland anal sac adenocarcinoma: 35 cases (2019-2023).
    Franca A; Stamenova P; Thompson JL
    J Small Anim Pract; 2024 Jun; 65(6):394-401. PubMed ID: 38594872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apocrine gland anal sac adenocarcinoma in cats: 30 cases (1994-2015).
    Amsellem PM; Cavanaugh RP; Chou PY; Bacon NJ; Schallberger SP; Farese JP; Kuntz CA; Liptak JM; Culp WTN; Robat CS; Powers BE
    J Am Vet Med Assoc; 2019 Mar; 254(6):716-722. PubMed ID: 30835176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective evaluation of canine heart base tumours treated with toceranib phosphate (Palladia): 2011-2018.
    Lew FH; McQuown B; Borrego J; Cunningham S; Burgess KE
    Vet Comp Oncol; 2019 Dec; 17(4):465-471. PubMed ID: 31069932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complications associated with iliosacral lymphadenectomy in dogs with metastatic apocrine gland anal sac adenocarcinoma.
    Huerta Y; De Mello Souza CH; Selmic LE; McGrath A; Skinner OT; Dark KV; Traverson M; Snell WL; Maxwell EA; Bertran J; Hasiuk MMM
    Can Vet J; 2022 Sep; 63(9):929-934. PubMed ID: 36060485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of dogs with apocrine gland anal sac adenocarcinoma treated via modified closed anal sacculectomy (2015-2022).
    Davey EL; Prpich CY
    Vet Surg; 2024 Aug; 53(6):973-979. PubMed ID: 38477012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety evaluation of combination carboplatin and toceranib phosphate (Palladia) in tumour-bearing dogs: A phase I dose finding study.
    Wouda RM; Hocker SE; Higginbotham ML
    Vet Comp Oncol; 2018 Mar; 16(1):E52-E60. PubMed ID: 28799187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs: 42 cases (2005-2011).
    Potanas CP; Padgett S; Gamblin RM
    J Am Vet Med Assoc; 2015 Apr; 246(8):877-84. PubMed ID: 25835172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985-1995).
    Williams LE; Gliatto JM; Dodge RK; Johnson JL; Gamblin RM; Thamm DH; Lana SE; Szymkowski M; Moore AS;
    J Am Vet Med Assoc; 2003 Sep; 223(6):825-31. PubMed ID: 14507100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of methods to determine primary tumour size in canine apocrine gland anal sac adenocarcinoma.
    Schlag AN; Johnson T; Vinayak A; Kuvaldina A; Skinner OT; Wustefeld-Janssens BG
    J Small Anim Pract; 2020 Mar; 61(3):185-189. PubMed ID: 31960434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short- and long-term outcomes associated with anal sacculectomy in dogs with massive apocrine gland anal sac adenocarcinoma.
    Griffin MA; Mayhew PD; Culp WTN; Giuffrida MA; Telek S; Singh A; Oblak M; Swanton E
    J Am Vet Med Assoc; 2023 Oct; 261(10):1-8. PubMed ID: 37225157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical hypocalcemia following surgical resection of apocrine gland anal- sac adenocarcinomas in 3 dogs.
    Olsen JA; Sumner JP
    Can Vet J; 2019 Jun; 60(6):591-595. PubMed ID: 31156257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of electrochemotherapy in the management of apocrine gland anal sac adenocarcinomas in dogs: A retrospective study.
    Valenti P; Menicagli F; Baldi A; Barella G; Catalucci C; Attorri V; Spugnini EP
    Open Vet J; 2021; 11(1):100-106. PubMed ID: 33898290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced-stage canine nasal carcinomas with toceranib phosphate: 23 cases (2015-2020).
    Merino-Gutierrez V; Borrego JF; Puig J; Hernández A; Clemente-Vicario F
    J Small Anim Pract; 2021 Oct; 62(10):881-885. PubMed ID: 34131916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of expression and function of vascular endothelial growth factor receptor 2, platelet derived growth factor receptors-alpha and -beta, KIT, and RET in canine apocrine gland anal sac adenocarcinoma and thyroid carcinoma.
    Urie BK; Russell DS; Kisseberth WC; London CA
    BMC Vet Res; 2012 May; 8():67. PubMed ID: 22630170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.